Gerresheimer stock

GXI · Xetra · EUR

Compare Gerresheimer
€31.56Change from previous close: −4.36%Absolute change: −€1.44

Close · November 20, 2026

Price history

+33.96% over the period

1 year: from €23.56 (November 20, 2025) to €31.56 (November 20, 2026), +33.96%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026€31.56
October 30, 2026€32.04
September 30, 2026€28.94
August 31, 2026€28.12
July 31, 2026€27.54
June 30, 2026€27.82
May 29, 2026€27.20
April 30, 2026€24.54
March 31, 2026€19.62
February 27, 2026€16.95
January 30, 2026€25.22
December 30, 2025€27.58
November 28, 2025€26.54
November 20, 2025€23.56

At a glance

  • The company

    Provide drug containment and delivery solutions including prefillable syringes, glass vials, plastic packaging, inhalers and diagnostic devices

  • Latest results

    Quarter to September 30, 2026 · EPS €0.61 (estimate €0.27)

TickerLandia's take on Gerresheimer

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low€14.83
52-wk high€34.20

−7.72% from the 52-week high

Analysts · 13 analysts

Average target€27.54−12.73% vs. price

Buy 2 · Hold 7 · Sell 4 · Hold

TickerLandia Fingerprint: Gerresheimer

Compared with similar companies: very low profitability, very low price, and very low financial strength.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Gerresheimer is cheaper than similar companies

Gerresheimer's Forward P/E: 12.7, −38% against the median of a group of 11 similar companies (20.6).

Compared with 11 similar companies

Gerresheimer's metrics compared with similar companies
MetricGerresheimerPosition in the groupBand
Forward P/E12.7Low
Operating margin1.6%Low
ROE-32.4%Low
Debt/equity2.37High
Price/book1.13Low

Grey band: the middle half of the group; tick: the median; dot: Gerresheimer. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€474.94M

Latest quarter · Q to Feb 2026

Net income

-€98.32M

Latest quarter · Q to Feb 2026

Quarterly net margin

-20.7%

Latest quarter · Q to Feb 2026

Numbers and valuation

Full valuation
Market cap
€1.09B
EPS
-€11.86
Volume
4.12K
Daily trading
€5.01M

How Gerresheimer is changing

All results
  • Revenue grew 10.3% a year on average over the last 5 years

  • Operating margin fell from 10.3% to 4.5%

  • Shares outstanding up 10.0% in 5 years

Returns

Gerresheimer returns with dividends

€1,000 invested in Gerresheimer 5 years ago, on November 22, 2021, would be worth €407 today with dividends reinvested: −59.25% in total, −16.45% per year. On price alone it would be €391 (−60.89%).

PeriodGerresheimerDAX€1,000 becomes
1 month−3.66%−1.98%€963
6 months+21.95%+0.26%€1,219
Year to date+14.43%+1.28%€1,144
1 year+33.96%+6.55%€1,340
3 years−62.95%+55.98%€370
5 years−59.25%+53.90%€407
10 years−47.35%+132.12%€527

Over the last 6 months it has done better than 94% of the stocks in the Materials sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. DAX: with dividends. Calculate your investment

The chart in detail

Gerresheimer: technical analysis

Gerresheimer is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 74.0% below its all-time closing high (€121.60, September 1, 2023).

Trend
Upward
RSI (14 sessions)
51
Between 30 and 70
vs 200-session average
+22.75%

Active signals

  • The price is moving in an unusually narrow range compared with the last year.

    since November 12, 2026

Support and resistance

Price areas where Gerresheimer has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price€31.56
  3. Support€30.15−4.48%4 touches, last on November 6, 2026
  4. Support€28.27−10.44%4 touches, last on August 19, 2026
  5. Support€27.47−12.97%3 touches, last on February 10, 2026

Volatility and risk

Over the last year it has moved little with the DAX.

Beta (1 year) vs DAX
0.17
Volatility (60 sessions, annualised)
42.5%
Largest fall in the last year
−44.17%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Gerresheimer: seasonality

Average monthly price change over 20 years

−1.5%Jan+0.5%Feb−0.6%Mar+5.5%Apr+2.3%May−1.5%Jun+2.9%Jul+1.8%Aug−3.6%Sep−3.2%Oct+2.3%Nov−0.5%Dec

Over the last 20 years, the strongest month for Gerresheimer has been April: +5.51% on average, positive in 12 years out of 19. The weakest has been September: −3.60% on average, positive in 7 years out of 20. November, the current month, has been positive in 10 years out of 19 (+2.30% on average).

Show chart data
MonthAverageMedianPositive years
January−1.50%0.00%9 of 19
February+0.54%−0.86%9 of 19
March−0.62%−0.21%9 of 19
April+5.51%+1.43%12 of 19
May+2.25%+2.47%14 of 19
June−1.53%+0.29%11 of 19
July+2.87%+2.67%11 of 20
August+1.84%+1.85%11 of 20
September−3.60%−3.22%7 of 20
October−3.21%−4.51%7 of 20
November+2.30%+0.20%10 of 19
December−0.53%+1.95%13 of 19

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Gerresheimer and its competitors

Serving customers in Germany and internationally, Gerresheimer AG and its subsidiaries supply drug containment solutions across three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. Its range covers prefillable syringes, vials, glass cartridges and ampoules, plastic and glass packaging, and drug delivery devices such as inhalers and auto injectors, alongside diagnostic and medical products including point-of-care tests, lancing devices and infusion sets.

Headquarters
Düsseldorf, Germany
Employees
13,301
Founded
1864
Chief executive
Uwe Röehrhoff
Gerresheimer and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
GerresheimerGXI$1.19B1.6%—+21.95%
Safilo GroupSFL$972.72M7.2%19.1+30.89%
Bonesupport HoldingBONEX$2.03B25.5%78.1+25.60%
AddLifeALIF.B$2.11B8.9%33.5+17.73%
OttobockOBCK$2.68B18.7%19.0−31.33%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%

Same industry or related industries, similar size. Compare Gerresheimer with its competitors · Full profile